ABSTRACT
Drug release kinetics from matrix dosage form is governed by polymer swelling and erosion, drug dissolution/diffusion and polymeric combination. For the preparation of controlled release dosage form, hydrophilic, swellable polymers in optimum combination are essential. The major objective of the current study is to prepare Amoxicillin trihydrate-loaded bucco-matrix tablets by direct compression technique and to study the effect of ratio of HPMCK100M and HPMCK15M used in the formulation on the basic properties and on drugrelease and permeation kinetics. The tablets offered satisfactory physicochemical results. The buccal strength, detachment force and bond strength of the tablets were good enough to hold the tablets in the buccal region. The drug release data generated during in vitro drug release study of bucco-matrix tablets in phosphate buffer pH 6.8 were evaluated by zero-order, first-order, Higuchi, Korsmeyer – Peppas, and Kopcha models. Release exponent (n) of Korsmeyer- Peppas equation of the formulations exhibited diffusion as the principal mechanism of drug release. It was further confirmed by Kopcha model. Evaluation of diffusion and erosion terms in the Kopcha model showed that diffusion dominated swelling or erosion process through out the study. The permeation kinetics of the drug showed linearity when studied across goat buccal mucosa. Permeation coefficient of drug decreased with increase in % swelling index of the formulations.
ABSTRACT
Over the recent past, many of the research groups are focusing their research on this technology. Amongst Oral drug delivery system Oral Strip Technology (OST) is gaining much attention. The advantages of OST are the administration to pediatric and geriatric patient population where the difficulty of swallowing larger oral dosage forms is eliminated. This technology has been used for local action, rapid release products and for buccoadhesive systems that are retained in the oral cavity to release drug in controlled fashion. OST offers an alternate platform for molecules that undergo first pass metabolism and for delivery of peptides. An ideal OST should have the following properties: high stability, transportability, ease of handling and administration, no special packaging material and/or processing requirements, no water necessary for application, and a pleasant taste. All these requirement are fulfilled by the oral films. The OST is a good tool for product life cycle management for increasing the patent life of existing molecules or products. Compared to some of the complicated and expensive process (like lyophilization) used to manufacture ODTs(Orally Disintegrating Tablets), the OST is relatively easy to fabricate,thus reducing the overall cost of the therapy. One of the reasons is that the buccal mucosa is less permeable and is thus not able to elicit a rapid onset of absorption and hence better suited for formulations that are intended for sustained release action. Further, the buccal mucosa being relatively immobile mucosa and readily accessible, it makes it more advantageous for retentive systems used for oral trans mucosal drug delivery. The primary disadvantage associated with buccal delivery route is the low flux that in turn results in low drug bioavailability. To overcome this hurdle, various buccal penetration enhancers have been studied which improve the absorption pattern of the molecules. The article shows OST encompassing materials used in OST, method of preparation, evaluation, applications, commercial technologies and future Business prospects of this technology.